Individuals with psychiatric disorders have elevated rates of autoimmune comorbidity and altered immune signaling. It is unclear whether these altered immunological states have a shared genetic basis with those psychiatric disorders. The present study sought to use existing summary-level data from previous genome-wide association studies (GWASs) to determine if commonly varying single nucleotide polymorphisms (SNPs) are shared between psychiatric and immune-related phenotypes. We estimated heritability and examined pair-wise genetic correlations using the linkage disequilibrium score regression (LDSC) and heritability estimation from summary statistics (HESS) methods. Using LDSC, we observed significant genetic correlations between immune-related disorders and several psychiatric disorders, including anorexia nervosa, attention deficit-hyperactivity disorder, bipolar disorder, major depression, obsessive compulsive disorder, schizophrenia, smoking behavior, and Tourette syndrome. Loci significantly mediating genetic correlations were identified for schizophrenia when analytically paired with Crohn's disease, primary biliary cirrhosis, systemic lupus erythematosus, and ulcerative colitis. We report significantly correlated loci and highlight those containing genome-wide associations and candidate genes for respective disorders. We also used the LDSC method to characterize genetic correlations amongst the immune-related phenotypes. We discuss our findings in the context of relevant genetic and epidemiological literature, as well as the limitations and caveats of the study.
Introduction
The biological bases of major psychiatric disorders have been studied for decades, yet they remain largely unresolved. Evidence from both clinical and biomedical literature has demonstrated that individuals with these conditions show differences in circulating immunologic markers, functional capacities of isolated immune cells, and atypical prevalence of clinical immune-related phenotypes compared to individuals not affected by psychiatric or neurodevelopmental disorders. [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] It remains unclear what roles (if any) altered immunologic functions may play in the major psychiatric phenotypes, though plausible mechanisms linking altered immune functions with neurobiological changes during early brain development and in fully developed adults have been identified. [11] [12] [13] [14] [15] [16] [17] [18] While some studies have already suggested potential genetic bases for the immune dysregulation observed in a subset of psychiatric patients, [19] [20] [21] [22] the extent to which co-occurrence or segregation of clinical phenotypes may be influenced by similarities in genome-wide genetic risk signals warrants further examination. Genomewide association studies (GWASs) and meta-analyses can shed light on the regions of the genome that tend to associate with a clinical phenotype, quantitative trait, or biomarker; this is accomplished through tagging and association-testing of single nucleotide polymorphisms (SNPs) that vary within the population. Recently developed methods like linkage disequilibrium (LD) score regression (LDSC) 23 and Heritability Estimation from Summary Statistics (HESS) 24 allow for direct comparison of GWAS summary statistics for two different phenotypes for quantitative assessment of genetic correlation.
In the present study, we leveraged existing data to explore the genetic associations of a set of medical phenotypes that are enriched with immune and inflammatory processes; these included allergic conditions, classic autoimmune diseases, other inflammatory diseases, and vulnerability to infectious disease. We sought to cross-correlate the genetic associations of these phenotypes with the associations obtained from studies of a set of psychiatric and behavioral phenotypes. We hypothesized that some phenotype-pairs with evidence for increased clinical comorbidity might also share similarities in their genome-wide association profile, which would be reflected in our analyses as significant positive correlations. Additionally, in light of literature suggesting shared genetic risk among some immune and inflammatory disorders, we assessed genetic correlations within this set of phenotypes using the LDSC method; these findings are reported within the Supplementary Materials. Genetic correlations within the set of psychiatric phenotypes have been reported previously 23, 25, 26 and are not examined in the present study.
Materials and Methods

Literature Search
We searched the published literature (Pubmed, SCOPUS), data repositories (dbGaP and immunobase.org), and the downloads page of the Psychiatric Genomics Consortium (PGC) website (https://www.med.unc.edu/pgc/downloads) to identify phenotypes with potentially usable GWAS and GWAS meta-analysis summary statistics. For studies identified in the published literature, we contacted corresponding authors to request summary statistics. In order to facilitate cross-study comparison, we utilized studies that reported samples of European ancestry, broadly defined to include Central, Southern and Eastern Europe, Scandinavia, and Western Russia. Our initial search yielded a large number of datasets reflecting a wide-range of behavioral and immune-related phenotypes (Supplementary Table 1) ; the set of phenotypes ultimately retained for final analyses was selected based on criteria described below.
When multiple studies were identified for a given phenotype, we pursued the studies with the largest effective sample sizes and ultimately used the available study with the largest heritability z-score. In several instances, data from the largest existing studies could not be shared or reflected a mixed-ancestry meta-analysis; in these cases, we deferred to the next largest European-ancestry study. We chose to retain datasets with an effective sample size greater than 5000 individuals and with estimated SNP heritability zscore > 3, in keeping with previous recommendations. 23 This filter resulted in the exclusion of many relevant immune-related phenotypes, including eosinophilic esophagitis, 27 granulomatosis with polyangiitis, 28 IgA nephropathy, 29 HIV-related neurocognitive phenotypes, 30 morning cortisol levels, 31 myeloid leukemias, 32 psoriatic arthritis, 33 sarcoidosis, 34 and systemic sclerosis. 35 This also resulted in exclusion of several psychiatric and behavior phenotypes, including adolescent alcohol abuse, 36 anxietyspectrum disorders, 37 borderline personality disorder, 38 language impairment, 39 personality domains (five factor model), 40 post-traumatic stress disorder, 41 and reading disability. 42 We also ultimately excluded data from studies of ethanol, opiate, and cocaine dependence, [43] [44] [45] as genetic correlations involving these phenotypes were frequently outside the boundaries tolerated by the LDSC software, making them difficult to interpret; this may have been related to the ordinal-ranked phenotypes used in the GWASs. Finally, while relationships between tobacco-smoking behavior and other psychiatric phenotypes have been examined previously, 23, 25 we chose to retain smoking data in order to assess relationships with a more complete set of immune-related phenotypes. The full list of phenotypes identified in the search and retained for analyses is shown in Supplementary Table 1 , along with identification of the study cohorts and consortia that generated these data, full citations of the respective publications, and indications of sample size, information regarding genomic inflation, and estimated SNP heritability.
GWAS Phenotypes Retained for Genetic Correlation
For our psychiatric and behavior-related phenotypes, we ultimately retained GWAS summary data reflecting studies of Alzheimer's disease, 46 angry temperament 47 , anorexia nervosa, 48 attention deficit-hyperactivity disorder (ADHD), 49 autism, 50 bipolar disorder (BD), 51, 52 cigarette smoking (eversmoked status), 53 major depressive disorder, 54 trait neuroticism, 55 obsessive-compulsive disorder (OCD), 56 Parkinson's disease, 57 schizophrenia (SZ), 58 and Tourette Syndrome (personal communication from PGC Working Group). Collectively, these phenotypes were treated as a set. For phenotypes that are known or suspected to involve alterations to immune cells and/or inflammatory signaling, we ultimately retained GWAS data reflecting allergy (any, self-reported), 57, 59 asthma (self-reported), 57 atopic dermatitis, 60 childhood ear infection (self-reported), 57 celiac disease, 61 serum C-reactive protein (CRP), 62 Crohn's disease (CD), 63, 64 hypothyroidism (self-reported), 57 primary biliary cirrhosis (PBC), 65 psoriasis, 66 rheumatoid arthritis, 67 systemic lupus erythematosus (SLE), 68 susceptibility to pulmonary tuberculosis, 69 type 1 diabetes, 70 and ulcerative colitis (UC). 71 These phenotypes were treated as a set in subsequent analyses.
Data Pre-Processing and Analysis
Our primary analyses were performed using the LDSC software (https://github.com/bulik/ldsc). 23 Briefly, this set of tools can be used with existing GWAS summary data in order to distinguish polygenicity from confounding caused by uncontrolled population stratification or cryptic relatedness among samples, 72 to estimate the heritability of a given phenotype, 23 and to estimate the genetic correlation between two phenotypes based on two separate or related sets of summary statistics. 23 In the latter application, the minimal requirements for each set of summary statistics include columns of data indicating SNP ID, the identities of reference and non-reference alleles, association 
Characterization of Genetically Correlated Loci and Associated Genes
For psychiatric-immune phenotype-pairs showing significant genetic correlations after BH correction for multiple testing, we used the HESS software to estimate partitioned heritability and genetic correlations based on smaller LD-based segments of the genome (average size = 1.5 Mb). We report the number and identity of genomic partitions (based on HG19 reference) displaying significant local genetic correlations and apply correction for the total number of partitions (≈1694, after MHC removal). Because presently available methods are poorly suited for fine-mapping the loci mediating a genetic correlation, we prioritized reporting correlated loci that also contain genome-wide significant associations for the relevant phenotypes (i.e., associations with p < 5x10 -8 ; subsequently called GW hits). We report GW hits contained within the present datasets, but also cross-reference these findings with those contained in immunobase.org, in order to identify loci associated with multiple immune-related disorders. We report the HGNC symbols for candidate genes proposed to mediate those associations. The full list of genes contained within each correlated loci is provided in Supplementary Table 3 . Additionally, we used HESS to examine patterns of local genetic correlation in relationship to GWAS hits to make inferences about putative causal directionality between the phenotype-pairs. For all HESS analyses, we used the 1000
Genomes Project Phase 3 European reference panel and the LD-independent genome partitions recommended by the software developers. 73 Following the developers' practices, we assumed no sample overlap for comparisons of data generated by different consortia.
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Results
Genome-Wide Correlations between Psychiatric and Immune-Inflammatory Phenotypes
All pair-wise LDSC genetic correlations between psychiatric and immune-related phenotypes are depicted in Figure 1 . Notably, twenty-one correlations survived BH correction for multiple testing (denoted with **) and 6 survived a more stringent Bonferroni correction (denoted with ***). Full results for these analyses are provided in Supplementary Table 2 significance (e.g., autism-allergy and OCD-celiac); these correlations tended to have a higher standard error and were generated using relatively smaller GWAS sample sizes. As such, they may be more likely to reflect false positives and should be regarded with appropriate skepticism.
For phenotypes involved in correlations that survived multiple test correction, estimated SNP heritability is shown in Table 2 . For these phenotypes, we reassessed SNP heritability and the magnitude of genome-wide genetic correlations using the HESS method (Tables 1 and 2 Table 5 .
Characterization of Loci Contributing to Psychiatric-Immune Genetic Correlations
For psychiatric-immune phenotype-pairs that demonstrated a significant genome-wide correlation with the LDSC method (i.e., those in Table 1 ), we used the HESS software to examine the genetic correlation within the ~1694 partitioned genomic loci. The number of correlated loci before and after BH multiple test correction are depicted in Table 3 ; detailed results for these analyses, including local heritability, correlation strength, and the lists of gene symbols within each loci are provided in Supplementary Table 3 . Only SZ displayed robust local genetic correlations with immune-related phenotypes, including thirty-two loci with CD, 37 loci with PBC, 20 loci with SLE, and 8 with UC (Table   3 , depicted in Figure 2 ). Upon closer examination of the loci implicated between SZ and CD, we noticed that five of these loci contained GW hits, including one locus on chromosome 4q24 (4:100678360-103221356; highlighted green in Figure 2 ) that contained GW hits for both SZ and CD within the present data, and with 4 other autoimmune diseases (immunobase.org); these signals are near autoimmunity candidate genes NFKB1 and MANBA, as well as proposed SZ candidate gene SLC39A8, among others contained within the locus (see Supplementary Table 3 ). The locus on 10p12. We also sought to examine whether the specific loci might be implicated across multiple psychiatric-immune disorder pairs ( Figure 2 ). An analysis limited to only those surviving BH correction for multiple testing yielded only two loci shared by multiple disease pairs. The first locus (within 3p24.3;
3:21643707-22204244) was identified in correlations of SZ with PBC and with CD; it contained no GWS hits and two genes of unclear consequence ZNF385D and ZNF385D-AS2. The second locus within 8p32.1 (8:11278998-13491775, highlighted brown) was identified in correlations of SZ with PBC and with SLE; this locus contained numerous genes and is adjacent to a GWS hit for SLE associated with candidate gene BLK. When we broadened the scope to examine all loci implicated in nominally significant correlations (uncorrected p < 0.05), we find several that are common to multiple psychiatricimmune disorder pairs ( Table 4 ). The most widely implicated locus was shared among the 5 pairs of psychotic and inflammatory bowel disorders (within 17q12; 17:36809344-38877404, highlighted purple) and contains a GW hit for BD ascribed to candidate gene ERBB2. There were another eight loci that were implicated in four disorder pairs. Among these, one located within 1q32. 
Discussion
In contrast to previous studies examining large sets of medical, anthropomorphic, metabolic, and behavioral phenotypes, [23] [24] [25] [26] 74 the present study performed a focused comparison of psychiatric and immune-related phenotypes using two methods to estimate genetic correlation from summary statistics.
We used updated versions of psychiatric GWASs [49] [50] [51] 56 and compiled a more comprehensive set of immune-related phenotypes, while simultaneously reducing the burden imposed by multiple testing.
Additionally, this analysis reflects the first application of the LDSC and HESS method for some of these phenotype-pairs. We identified several genome-wide correlations that were robust to multiple testing.
Furthermore, we used the HESS method to validate genome-wide correlations and to conduct a quantitative analysis that localizes correlations to regions of the genome. We prioritized the reporting of findings based on co-localization with GW hits. As such, this study provides a quantitative map of genetic relationships between psychiatric and immune-related disorders and serves, along with previous work, 75 as a starting point for identifying and characterizing potentially pleiotropic loci.
Prominent among the LDSC genome-wide significant findings was a cluster of modest positive correlations involving BD (rgs ranging 0.25 to 0.33) and SZ (rgs ranging 0.12 to 0.15) in conjunction with immune-related disorders involving the gastrointestinal tract (i.e., CD, PBC, UC). These findings are consistent with available epidemiological evidence indicating that the presence of one set of disorders portends increased risk for a diagnosis from the other class of disorders, though the causality and temporality of these relationships is not clearly established. [76] [77] [78] [79] [80] [81] [82] Positive genetic inter-correlations among these phenotypes are also consistent with recent work demonstrating that the positive correlation between BD and SZ are significantly mediated by both CNS and immunologic tissues. 83 Our local genetic correlation analyses were inadequately powered to detect loci relevant to most of the psychiatric-immune disorder pairs, including BD. However, comparisons with SZ yielded 97 loci that were robust to multiple test correction, 18 of which also were shown to harbor GW hits in previous studies. In several instances, these GW hits localize near genes with functions that are pleiotropic and relevant to both brain and immune system phenotypes. For example, we identified a SZ-CD correlated locus at 4q24 (4:100678360-103221356) that contained GW hits for both SZ (putatively attributed to SLC39A8) and several autoimmune diseases (putatively attributed to NFKB1 and MANBA); others have proposed that associations at this locus may exert pleiotropic effects on a wide range of phenotypes (additionally including body mass index, serum levels of manganese, N-terminal pro-B-type natriuretic peptide, and HDL-cholesterol) through a functional variant found in European populations affecting the SLC39A8 cation transporter. 84, 85 A locus within 11q23.3 (11:117747110-119215476) was significantly correlated between SZ and PBC and harbors a region of GW hits for multiple autoimmune disorders attributed to PLCL2, a catalytically inactive phospholipase-like protein thought to influence intracellular signaling, calcium homeostasis, and GABA-ergic receptor trafficking in immune and neuronal cell types, among others. [86] [87] [88] A de-novo missense mutation affecting this gene was identified in an exome sequencing study of SZ affected individuals, though no replication appears to have been reported. 89 Similarly, a correlated locus within 22q13.1 (22:39307894-40545797, highlighted yellow in Figure 2 ) contains GW hits for PBC, which overlaps with voltage gated calcium channel gene CACNA1I; this gene has been implicated by both GWAS and rare-variant studies of SZ. 58, 90 Another correlated locus within 11q23 (11:118579747-118743772) contained GW hits for multiple autoimmune disorders and is suspected to exert pleiotropic effects through several genes, whose functions include repression of aberrant interferon signaling (DDX6), 91 chemokine signaling between T-helper and B-cells (CXCR5), 92, 93 and enzymatic break down of microbial disaccharides (TREH). 94 Notably, functional genomic studies have identified DDX6 as a gene that is perturbed during neuronal differentiation of samples derived from individuals with schizophrenia, 95 and as a peripheral blood marker of cerebrospinal fluid serotonin metabolite levels, 96 supporting its relevance to psychiatric phenotypes.
We also examined loci that showed a nominal genetic correlation across multiple disorder pairs, and found these loci also harbored GW hits for respective phenotypes. The locus at 17q12 shared among multiple disorders contains a GW hit for BD (17:36809344-38877404) ascribed to candidate gene
ERBB2
. 52 This gene and its relatives encode receptor tyrosine kinases that interact with a family of growth factors called neuregulins to regulate the assembly of neural circuitry, myelination, neurotransmission and synaptic plasticity. A large body of evidence implicates both ligands and receptors from these families as susceptibility genes for SZ and BD. 97 Notably, ERBB2 overlaps with GW hits for multiple autoimmune disorders, though these have been attributed to different genes in the region.
Another locus at 1q32. KIF21B encodes a neuronal motor protein implicated in GABA A receptor trafficking, 100 in addition to having a suspected role in regulating inflammatory signaling in several lymphocyte subtypes.
101
While it is tempting to speculate about these observations, we must acknowledge limitations and caveats of the present approach. Current methods for assessing genetic correlations are not well-suited for fine-mapping shared liability across disorders; other methods are better suited for this task, including extensions of GWAS that model multiple phenotypes simultaneously. 22, 55, 102, 103 With respect to local genetic correlations, we have prioritized reporting of loci that co-localize with GW hits. However, this implies that the presence of the GW hit is contributing to the observed correlation, which we have not demonstrated presently. As such, our discussion of potentially pleiotropic loci and candidate genes should be considered anecdotal at this time. One indirect approach to assessing the role of GW hits in a local genetic correlation might be to re-estimate the local correlation after the removal of the smaller region of GW signal from the original datasets. When we conducted this analysis for the SZ-CD pair, we found that the number of significant loci (BH p < 0.05) was reduced from 32 to 8, suggesting that GW proportion of risk-associated loci; among these findings was a significant genetic overlap between BD (as well as SZ) and UC. 22 However, many of the other relationships identified in that study were not significant in the present study. Another recent study demonstrated that polygenic risk scores reflecting additive risk for several autoimmune diseases can explain a small proportion of variance in SZ casecontrol status, yet the genome-wide significant SNPs from the autoimmune GWASs were not overrepresented among SZ's genome-wide significant hits when permutation-based analysis was performed. 105 The apparent disagreement between different approaches for assessing shared genetic liability thus underscores the value of examining the consensus across studies and methods. 105 The LDSC approach featured here attempts to quantitate similarities and differences in association signals across the entire genome. Some of our phenotype-pairs have been examined previously using genome-wide assessment methods, yielding apparently contradictory findings. 25, 26, 72 For example, a previous study implementing a REML-based approach did not find significant SNP-based coheritabilities between CD and the major psychiatric phenotypes. 106 Additionally, the first study this idea is further supported by the observation that stratified genetic correlation analyses based on MAF thresholds can produce different levels of statistical significance and opposite patterns of correlation directionality. 83 Thus, our study suggests that genetic correlations between psychiatric and immunerelated disorders may be more significant when analyses are restricted to common variation.
Reassuringly, the developers of the HESS method use the same datasets examined presently, and also report positive genetic correlations between SZ and the inflammatory bowel disorders. 24 The results of the HESS analysis of putative causal directionality indicate that the local genetic correlations are higher in loci occupied by SZ GW hits, as compared to the loci harboring hits for the paired autoimmune disorders. 24 This pattern is consistent with the hypothesis that genetic liability toward SZ tends to impart a greater genetic risk for the corresponding paired disorder, rather than the opposite directional hypothesis. A related interpretation may be there is an unobserved intermediate phenotype (e.g., a shared biological pathways/mechanism) that is pleiotropic for both measured phenotypes, but more strongly influences the SZ phenotype. This pattern of findings could also be caused by the presence of a confounding factor (e.g., smoking, socioeconomic status) that portends risk for both phenotypes. 24 Thus, we caution against over-interpretation of these findings. Extensions of Mendelian randomization methods to incorporate two GWAS samples using multi-allelic risk stratifying instruments will be better suited to address these hypotheses, 107 especially as future GWASs provide well-powered genetic estimates of potentially relevant intermediate phenotypes (e.g., brain structure morphometry, circulating immune cell phenotypes, and serum cytokine levels). [108] [109] [110] Other limitations of the HESS method, including assumptions related to sample overlap and ancestry stratification, are discussed extensively by the method's developers. 24 Our study also identified many phenotype-pairs that demonstrated significant genome-wide correlations using the LDSC method, but for which HESS-based genome-wide and local genetic correlations could not be identified. This is unsurprising, given that the sample sizes for these phenotypes were generally below the recommended sample size for HESS analyses (N > 50,000). 24 Nonetheless, some of these relationships are supported by evidence from clinical and epidemiological studies, and thus may warrant follow-up using larger sample sizes and alternative methods for assessing genetic relationships. For example, we observed a modest positive correlation between self-reported hypothyroidism and major depression (rg = 0.33 + 0.09, p = 5.0x10 -4 ), as well as trait neuroticism (rg = 0.25 + 0.06, p = 7.2x10 -5 ). This could be consistent with two different sets of clinical observations. The first is that symptoms of depression are common in individuals with hypothyroidism, and that subclinical hypothyroidism could play a role in a subset of persons diagnosed with major depression; thus crosscontamination of GWAS samples could lead to a biased positive correlation. However, the second observation is that there is an increased incidence of major depression and depressive symptomatology in persons with autoimmune thyroiditis receiving hormone replacement therapy. 111, 112 It is worth noting that GWAS data for allergy, asthma, hypothyroidism, childhood ear infection, and Parkinson's disease were obtained through 23andMe, Inc.. These data are based on self-report, and thus could be more susceptible to bias stemming from misdiagnosis or misreporting, though previous work supports their validity. evidence of elevated CRP in persons who smoke, 126 and increased incidence of smoking behavior among individuals diagnosed with rheumatoid arthritis. 127 These findings may indicate a need for more adequate statistical treatment of smoking behavior in GWAS studies.
The present study identified a number of intriguing and previously unreported genetic correlations, some of which appear to localize near established risk factors for complex disease. On the whole, these findings are consistent with the idea that similar signatures of common genetic variation may increase risk for both psychiatric and immune-related disorders. However, it is important to keep in mind that these findings do not necessarily imply causality or even shared genetic etiology. SNP-based genetic correlations could arise from a wide variety of underlying factors, including the possibility that the relationship between phenotypes is mediated by behavioral or cultural factors, or influenced by a heritable but unexamined underlying trait that confers risk to both phenotypes. 23, 26 Other factors that could contribute to genetic correlations include effects mediated by parental genotypes and their influence on parental behaviors that impact the offspring. 128 Additionally, GWAS studies of psychiatric phenotypes typically do not screen affected cases on the presence of other medical conditions (and vice-versa), thus over-representation of a given phenotype in the sample of another phenotype could bias the data toward the detection of a genetic correlation. Finally, estimates of genetic similarities could be influenced by misdiagnosed cases. 129 Other general limitations of this method (in comparison with other approaches) have been discussed previously elsewhere. 23, 26 In light of the exploratory nature of the present study, another critique pertains to the lack of clearly identified positive and negative control comparisons.
Additionally, the clinical significance of weak or modest genetic correlations is yet unclear. Future work could shed light on this topic by comparing the strength of reported genetic correlations with estimates of effect size from epidemiological associations, in order to create an atlas of concordance and shed light on the sensitivity and specificity of these genetic methods. One final critique of this approach is that it falls short of identifying plausible genetic and biological mechanisms that mediate potentially pleiotropic loci.
Future work incorporating expression quantitative trait loci, differentially expressed or methylated genes, or enriched ontological and functional terms may provide a clearer context for assessing biological similarities between phenotypes. Despite these limitations, the present study indicates that shared aspects of common genetic variation may underlie long-recognized epidemiological links between psychiatric and immune-related disorders and serves as a start point for the identification and characterization of potentially pleiotropic loci.
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